Simultaneous delivery of therapeutic antagomirs with paclitaxel for the management of metastatic tumors by a pH-responsive anti-microbial peptide-mediated liposomal delivery system

J Control Release. 2015 Jan 10:197:208-18. doi: 10.1016/j.jconrel.2014.11.010. Epub 2014 Nov 15.

Abstract

The roles of microRNAs (miRNAs) in the regulation of metastasis have been widely recognized in the recent years. Mir-10b antagomir (antagomir-10b) was shown to impede metastasis through the down-regulation of mir-10b; however, it could not stunt the growth of primary tumors. In this study we showed that the co-delivery of antagomir-10b with paclitaxel (PTX) by a novel liposomal delivery system modified with an anti-microbial peptide [D]-H6L9 (D-Lip) could significantly both hinder the migration of 4T1 cells and induce evident cellular apoptosis and cell death in the meantime. The histidines in the sequence of [D]-H6L9 allowed the peptide to get protonated under pH5.0 (mimicking the lysosome/endosome environment), and strong membrane lytic effect could thus be activated, leading to the escape of liposomes from the lysosomes and the decrease of of mir-10b expression. The in vivo and ex vivo fluorescence imaging showed that D-Lip could reach 4T1 tumors efficaciously. Incorporation of PTX did not influence the antagomir-10b delivery effect of D-Lip; for the in vivo tumor inhibition assay, compared with all the other groups, the combination of antagomir-10b and PTX delivered by D-Lip could prominently delay the growth of 4T1 tumors and reduce the lung metastases at the same time, and the expression of Hoxd10 in tumors was also significantly up-regulated. Taken together, these results demonstrated that D-Lip could act as a sufficient tool in co-delivering antagomir-10b and PTX.

Keywords: Antagomir-10b; Co-delivery; Liposomes; Metastasis; [D]-H(6)L(9); anti-microbial peptides.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antimicrobial Cationic Peptides / administration & dosage*
  • Antineoplastic Agents, Phytogenic / administration & dosage*
  • Apoptosis / drug effects
  • Cell Line, Tumor
  • Erythrocytes / drug effects
  • Gene Silencing
  • Hemolysis
  • Hydrogen-Ion Concentration
  • Liposomes
  • Mice, Inbred BALB C
  • MicroRNAs / administration & dosage*
  • MicroRNAs / genetics
  • MicroRNAs / pharmacokinetics
  • Neoplasms / drug therapy*
  • Neoplasms / metabolism
  • Neoplasms / pathology
  • Paclitaxel / administration & dosage*
  • Rats
  • Tissue Distribution
  • Tumor Burden / drug effects
  • Wound Healing / drug effects

Substances

  • Antimicrobial Cationic Peptides
  • Antineoplastic Agents, Phytogenic
  • Liposomes
  • MIRN10 microRNA, human
  • MicroRNAs
  • Paclitaxel